REDWOOD CITY, Calif., Oct 22, 2008 (BUSINESS WIRE) -- Imaging Therapeutics, Inc has received marketing clearance from the United States Food and Drug Administration to market its OsDx(TM) Hip Bone Mineral Density (BMD) system. OsDx Hip BMD is a stand-alone x-ray image-processing software system intended to provide an estimate of BMD of the proximal femur using standard antero-posterior hip or pelvis radiographic images. This information may be used by physicians in the assessment of osteoporosis.
